Pfizer RSV vaccine candidate Phase 3 trial will focus on older adults

Pfizer has announced the third phase of clinical candidates for the RSV vaccine for older adults. The company called the third phase test ‘Renoir,’ noted that he involves giving RSVPref’s vaccine candidates to adults aged 60 and older. The company…